Skip to main content
R

Rua Bioscience Limited — Investor Relations & Filings

Ticker · RUA ISIN · NZRUAE0004S1 NZX Manufacturing
Filings indexed 229 across all filing types
Latest filing 2023-09-14 Regulatory Filings
Country NZ New Zealand
Listing NZX RUA

About Rua Bioscience Limited

https://www.ruabio.com

Rua Bioscience Limited specializes in the research, development, and manufacturing of pharmaceutical-grade medicinal cannabis products. The company focuses on the full value chain of medicinal cannabis, from advanced plant genetics and cultivation to the production of standardized cannabinoid-based medicines. Its product portfolio primarily includes high-quality dried flower and oil formulations designed for clinical applications. Rua Bioscience employs a capital-light business model, prioritizing intellectual property development and strategic partnerships to scale its global reach. The company targets international medicinal markets, with a significant focus on established pharmaceutical distribution channels in Europe and Australasia. By leveraging scientific expertise and sustainable production methods, the company aims to provide consistent, high-potency therapeutic options for patients while maintaining a strong commitment to its social enterprise origins.

Recent filings

Filing Released Lang Actions
Rua Releases Annual Report for Year Ended 30 June 2023
Regulatory Filings
2023-09-14 English
Rua Notice of 2023 Annual Shareholders’ Meeting
Regulatory Filings
2023-09-13 English
Launch of first product in Australia
Regulatory Filings
2023-09-04 English
Supply line strengthens with Schroll Medical Agreement
Regulatory Filings
2023-08-30 English
Rua Bioscience Annual Results
Regulatory Filings
2023-08-28 English
ASM date and Director Nominations
Regulatory Filings
2023-08-17 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.